Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E2 axis - Ming-Kai Tsai; Wen-Chin Lee; Shih-Chung Huang; Chao-Cheng Huang; Yi-Chen Wang; Chien-Han Yuan; Chih-Chiang Wang; Ching-Han Liu; Nan-Chieh Huang; Yi-Chen Chang; Cheng-Chieh Fang; Bi-Wen Yeh; et al. (Toxicology and Applied Pharmacology, 2025)